Alkem Laboratories Interim Dividend: Set Feb 14 As Record Date

The manufacturer of pharmaceutical and nutraceutical products, Alkem Laboratories Limited has set Feb 14, 2025, as the record date for its interim dividend for FY25. On February 07, 2025, Alkem Laboratories declared an interim dividend of ₹37. The company further stated that the interim dividend be paid on Feb 28, 2025.

Alkem Laboratories Record Date: What This Mean For Shareholders?

As Alkem Laboratories has set Feb 14 as the record date for its interim dividend, meaning that Feb 13, marks the last to buy Alkem Laboratories shares to become eligible for the interim dividend. Further, any shares bought on or after Feb 14 (record date), won’t be eligible for the interim dividend.

Alkem Laboratories Management Take on Q3FY25 Earnings

Commenting on the Q3FY25 results, Dr Vikas Gupta, CEO of Alkem, said, “We are pleased to share that the actions we have taken to improve profitability continue to deliver positive results. By concentrating on higher-margin offerings, better aligning with market needs, and implementing cost-saving strategies to reduce inefficiencies, we are seeing growth in our EBITDA margins. Within the domestic market, our focus is on expanding the presence of our flagship brands and strategically enhancing our portfolio. Looking ahead, we are confident that these initiatives will continue to drive sustainable growth and strengthen our market position.”

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in securities market are subject to market risks, read all the related documents carefully before investing.